Full Length Research Paper
References
|
Abdulaziz A, Ahmad AJ, Abdullah AA (2018). Prevalence of Multidrug Resistance and Extended-Spectrum β-Lactamase Carriage of Clinical Uropathogenic Escherichia coli Isolates in Riyadh, Saudi Arabia. International Journal of Microbiology pp. 1-9. |
|
|
Adenipekun EO, Jackson CR, Ramadan H, Iwalokun BA, Oyedeji KS, Frye JG, Barrett JB, Hiott LM, Woodley TA, Oluwadun A (2016). Prevalence and multidrug resistance of Escherichia coli from community-acquired infections in Lagos, Nigeria. Journal of Infection in Developing Countries 10(9):20-931. |
|
|
Adesola O, Onwugamba F, Iwalokun B, Mellmann A, Becker K, Schaumburg F (2020). High proportion of carbapenemase-producing Escherichia coli and Klebsiellapneumoniae among extended-spectrum β-lactamase-producers in Nigerian hospitals. Journal of Global Antimicrobial Resistance 21:8-12. |
|
|
Aibinu I, Aednipekun E, Odugbemi T (2004). Emergence of quinolone resistance amongst Escherichia coli strains isolated from clinical infections in some Lagos state hospitals, in Nigeria. Nigerian Journal of Health and Biomedical Sciences 3(2):73-78. |
|
|
Aibinu IE, Ohaegbulam VC, Ademipekun EO, Ogunsola FT, Odugbemi TO, Mee BJ, (2003). Extended-spectrum beta-lactamase enzymes in clinical isolates of Enterobacter species from Lagos, Nigeria. Nigerian Journal of Health and Biomedical Sciences 2:53-60. |
|
|
Aworh MK, Kwaga J, Okolocha E, Mba N, Thakur S (2019). Prevalence and risk factors for multi-drug resistant Escherichia coli among poultry workers in the Federal Capital Territory, Abuja, Nigeria. PLoS ONE 14(11):e0225379. |
|
|
Bajpai T, Pandey M, Varma M, Bhatambare GS (2017). Prevalence of TEM, SHV, and CTX-M Beta-Lactamase genes in the urinary isolates of a tertiary care hospital. Avicenna Journal of Medicine 7(1):12-16. |
|
|
Bauer AW, Kirby WMM, Sherris JKC, Turk MN (1996). Antibiotic susceptibility testing by a standardized single disc method. American Journal of Clinical Pathology 45(4):413-496. |
|
|
Bikandi J, San Millán R, Rementeria A, Garaizar J (2004). In silico analysis of complete bacterial genomes: PCR, AFLP-PCR and endonuclease restriction.Bioinformatics Application Note 20(5):798-799. |
|
|
Bonnet RG (2004). Group of extended-spectrum beta-lactamases: the CTX-M enzymes. Antimicrobial Agents and Chemotherapy 48(1):1â€14. |
|
|
Chaudary U, Aggarwal R (2004). Extended spectrum beta lactamases; AN emerging threat to clinical therapeutics. Indian Journal of Medical Microbiology 22(2):75-80. |
|
|
Chika E, Ifeanyichukwu I, Clement OA, Malachy U, Peter E, Iroha CS, Ogene L, Chinedu O (2017). Multiple Antibiotic Resistance, Antibiogram and Phenotypic Detection of Metallo-Beta- Lactamase (MBL) from Escherichia coli of Poultry Origin. Journal of Applied Microbiology and Biochemistry 1(4):15-20. |
|
|
Clinical Laboratory Standard Institute (CLSI) (2013). Performance Standard for Antimicrobial Disk and Dilution Susceptibility Test for Bacteria Isolated from Animals; Approved Standard - Third edition. CLSI document M31-3A, Wayne, PA: C L SI 24 p. |
|
|
Coudron PE, Moland ES, Sanders CC (1997). Occurrence and Detection of Extended-Spectrum b-Lactamases in Members of the Family Enterobacteriaceae at a Veterans Medical Center. Journal of Clinical Microbiology 35(10):2593-2597. |
|
|
Falgenhauer L, Imirzalioglu C, Oppong K, Akenten CW, Hogan B, Krumkamp R, Poppert S, Levermann V, Schwengers O, Sarpong N, Owusu-Dabo E, May J, Eibach D (2019). Detection and Characterization of ESBL-Producing Escherichia coli From Humans and Poultry in Ghana . Frontiers in Microbiology 9:3358. |
|
|
Founou LL, Founou RC, Allam M, Ismail A, Djoko CF, Essack SY (2018). Genome Sequencing of Extended-Spectrum β-Lactamase (ESBL)-Producing Klebsiellapneumoniae Isolated from Pigs and Abattoir Workers in Cameroon. Frontiers in Microbiology 9:188-199. |
|
|
Hassuna NA, Khairalla AS, Farahat EM, Hammad AM, Abdel-Fattah M (2020). Molecular characterization of Extended-spectrum β lactamase- producing E. coli recovered from community-acquired urinary tract infections in Upper Egypt. Scientific Report 10:2772. |
|
|
Horsefall SJ, Abbey SD, Nwokah E, Okonko IO (2017). Prevalence of Extended-Spectrum Beta-lactamases (ESBLs) and Plasmid status of Escherichia coli and Klebsiellapneumoniae isolates from clinical sources in UPTH, Port-Harcourt, Nigeria. New York Scientific Journal 10(3):29-39. |
|
|
Husam SK, Khalid MB, Abiola CS, Giuseppe AB (2009). Extended spectrum beta-lactamases (ESBL) in Escherichia coli and Klebsiellapneumoniae: trends in the hospital and community settings. Journal of Infections in Developing Countries 3:295-299. |
|
|
Igwe JC, Olayinka BO, Ehnimidu JO, Onaolapo JA (2016) Virulent Characteristics of Multidrug Resistant E. coli from Zaria, Nigeria. Clinical Microbiology 5(6):268. |
|
|
Irith W, Heinrich KG, Dietrich M, Enno S, Harald S (2007). Detection of Extended-Spectrum Beta-Lactamases among Enterobacteriaceae by Use of Semi-automated Microbiology Systems and Manual Detection Procedures. Journal of Clinical Microbiology 45:1167-1174. |
|
|
Iroha IR, Amadi ES, Oji AE, Nwuzo AC, Ejike-Ugwu PC (2010). Detection of Plasmid Borne Extended Spectrum Beta-Lactamse Enzymes from Blood and Urine isolates of Gram-negative Bacteria from a University Teaching Hospital in Nigeria. Current Research in Bacteriology 3:77-83. |
|
|
Kruse H, Sørum H (1994). Transfer of multiple drug resistance plasmids between bacteria of diverse origins in natural microenvironments. Applied and Environmental Microbiology 60(11):4015â€4021. |
|
|
Oli AN, Eze DE, Gugu TH, Ezeobi I, Maduagwu, UN, Ihekwereme CP (2017). Multi-antibiotic resistant extended-spectrum beta-lactamase producing bacteria pose a challenge to the effective treatment of wound and skin infections. Pan African Medical Journal 27:66-77. |
|
|
Olugbenga OA, Adewumi O, Odewale G, Ojurongbe O, Adefioye OJ (2015). Phenotypic and Molecular Characterisation of Extended-Spectrum Beta-Lactamase Producing Escherichia coli Obtained from Animal Fecal Samples in Ado Ekiti, Nigeria. Journal of Environmental and Public Health 7 p. |
|
|
Onyedibe KI, Shobowale EO, Okolo MO, Iroezindu MO, Afolaranmi TO, Nwaokorie FO, Opajobi SO, Isa SE, Egah DZ (2018). Low Prevalence of Carbapenem Resistance in Clinical Isolates of Extended Spectrum Beta Lactamase (ESBL) Producing Escherichia coli in North Central, Nigeria. Advances in Infectious Diseases 8:109-120. |
|
|
Paterson DL, Ko WC, Von Gottberg A, Mohapatra S, Casellas M, Goossens H, Mulazimoglu L, Trenholme G, Klugman KP, Bonomo RA, Rice LB, Wagener MM, McCormack JG (2004). Antibiotic therapy for Klebsiellapneumoniae bacteremia: implications of production of extended-spectrum beta-lactamases. Clinical and Infectious Disease 39(1):31-37. |
|
|
Piroth L, Aube H, Doise JM, Martin MV (1998). Spread of ESBL-producing K. pneumoniae: are β-lactamase inhibitors of therapeutic value?. Clinical and Infectious Disease 27:76-80. |
|
|
Sambrook J, Fritsch EF (1989). Maniatis T.Isolation of high molecular weight DNA from mammalian cells. Molecular Cloning, a Laboratory Manual 1:9-14. |
|
|
Saravanan M, Ramachandran B, Barabadi H (2018). The prevalence and drug resistance pattern of extended spectrum β-lactamases (ESBLs) producing Enterobacteriaceae in Africa. Microbial Pathogens 114:180-192. |
|
|
Shaikh S, Fatima J, Shakil S, Rizvi SM, Kamal MA (2015). Antibiotic resistance and extended spectrum beta-lactamases: Types, epidemiology and treatment. Saudi Journal of Biological Sciences 22(1):90-101. |
|
|
Wani KA, Thakur MA, Siraj FA, Fomdia B, Gulnaz B, Maroof P (2009). Extended Spectrum B-Lactamase Mediated Resistance in Escherichia coli in a Tertiary Care Hospital. International Journal of Health Sciences 3:155-163. |
|
|
Yusuf I, Arzai AH, Umar A, Magaji N, Salisu N, Tukur A, Hamid KM, Haruna M (2011). Prevalence of Extended Spectrum β-Lactamases (ESBL) producing Escherichia coli. Bayero Journal of Pure and Applied Sciences 4(2):182-185. |
|
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
